CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+16.29%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.82B
AUM Growth
+$7.82B
(+20%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
875
New
65
Increased
352
Reduced
239
Closed
80
Top Buys
| 1 |
Merck
MRK
|
$46.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$29.1M |
| 3 |
Gilead Sciences
GILD
|
$27.9M |
| 4 |
BZUN
Baozun
BZUN
|
$26.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$26.5M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$81.1M |
| 2 |
Danaher
DHR
|
$31.9M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$28.1M |
| 4 |
Agilent Technologies
A
|
$28M |
| 5 |
McCormick & Company Non-Voting
MKC
|
$20.1M |
Sector Composition
| 1 | Healthcare | 33.36% |
| 2 | Technology | 16% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 7.82% |